147
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Treatment of experimental pancreatic cancer with 213-Bismuth-labeled chimeric antibody to single-strand DNA

, , , , , , , , & show all

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Chandan Kumar, Neena Shetake, Sejal Desai, Amit Kumar, Grace Samuel & Badri N. Pandey. (2016) Relevance of radiobiological concepts in radionuclide therapy of cancer. International Journal of Radiation Biology 92:4, pages 173-186.
Read now

Articles from other publishers (12)

Rubin Jiao, Kevin J. H. Allen, Mackenzie E. Malo, Orhan Yilmaz, John Wilson, Bryce J. B. Nelson, Frank Wuest & Ekaterina Dadachova. (2023) A Theranostic Approach to Imaging and Treating Melanoma with 203Pb/212Pb-Labeled Antibody Targeting Melanin. Cancers 15:15, pages 3856.
Crossref
E. Dadachova. 2021. Biological Mechanisms and the Advancing Approaches to Overcoming Cancer Drug Resistance. Biological Mechanisms and the Advancing Approaches to Overcoming Cancer Drug Resistance 261 271 .
Ashleigh Hull, Yanrui Li, Dylan Bartholomeusz, William Hsieh, Barry Allen & Eva Bezak. (2020) Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma: A Review of the Current Status of Literature. Cancers 12:2, pages 481.
Crossref
Rubin Jiao, Kevin J. H. Allen, Mackenzie E. Malo, Muath Helal, Zewei Jiang, Karishma Smart, Susan V. Buhl, David Rickles, Ruth A. Bryan & Ekaterina Dadachova. (2019) Evaluation of novel highly specific antibodies to cancer testis antigen Centrin‐1 for radioimmunoimaging and radioimmunotherapy of pancreatic cancer. Cancer Medicine 8:11, pages 5289-5300.
Crossref
Dongjian Zhang, Meng Gao, Qiaomei Jin, Yicheng Ni & Jian Zhang. (2019) Updated developments on molecular imaging and therapeutic strategies directed against necrosis. Acta Pharmaceutica Sinica B 9:3, pages 455-468.
Crossref
Alexander H Staudacher, Vasilios Liapis & Michael P Brown. (2018) Therapeutic targeting of tumor hypoxia and necrosis with antibody α-radioconjugates. Antibody Therapeutics 1:2, pages 55-63.
Crossref
Benjamin B. Kasten, Abhishek Gangrade, Harrison Kim, Jinda Fan, Soldano Ferrone, Cristina R. Ferrone, Kurt R. Zinn & Donald J. Buchsbaum. (2018) 212Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse models. Nuclear Medicine and Biology 58, pages 67-73.
Crossref
Wei Fan, Wen Shi, Wenting Zhang, Yinnong Jia, Zhengyuan Zhou, Susan K. Brusnahan & Jered C. Garrison. (2016) Cathepsin S-cleavable, multi-block HPMA copolymers for improved SPECT/CT imaging of pancreatic cancer. Biomaterials 103, pages 101-115.
Crossref
Rebecca Phaeton, Zewei Jiang, Ekaterina Revskaya, Darrell R. Fisher, Gary L. Goldberg & Ekaterina Dadachova. (2015) Beta emitters rhenium‐188 and lutetium‐177 are equally effective in radioimmunotherapy of HPV ‐positive experimental cervical cancer . Cancer Medicine 5:1, pages 9-16.
Crossref
M Shah, R Da Silva, C Gravekamp, S K Libutti, T Abraham & E Dadachova. (2015) Targeted radionuclide therapies for pancreatic cancer. Cancer Gene Therapy 22:8, pages 375-379.
Crossref
R Phaëton, J Gutierrez, Z Jiang, RG Karabakhtsian, J Albanese, J Sunkara, DR Fisher, GL Goldberg & E Dadachova. (2015) Naive and radiolabeled antibodies to E6 and E7 HPV-16 oncoproteins show pronounced antitumor activity in experimental cervical cancer. Immunotherapy 7:6, pages 631-640.
Crossref
Marie Sahlin, Monika Posaric Bauden, Roland Andersson & Daniel Ansari. (2015) Radioimmunotherapy—a potential novel tool for pancreatic cancer therapy?. Tumor Biology 36:6, pages 4053-4062.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.